SCM
OGN icon

Smead Capital Management’s Organon & Co OGN Stock Holding History

Smead Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,295,225
Closed -$43.7M – 30
2022
Q2 		$43.7M Buy
1,295,225
+80,183
+7% +$2.81M 1.12% 25
2022
Q1 		$42.4M Buy
1,215,042
+997,700
+459% +$34.1M 0.98% 25
2021
Q4 		$6.62M Buy
217,342
+41,228
+23% +$1.34M 0.17% 26
2021
Q3 		$5.78M Buy
176,114
+4,259
+2% +$136K 0.2% 26
2021
Q2 		$5.2M Buy
+171,855
New +$5.66M 0.18% 30

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Smead Capital Management's OGN Position: Q3 2022 in Review

Smead Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 1,295,225 shares — an estimated $43.7M sold.

Smead Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $43.7M in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Smead Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Smead Capital Management sold 1,295,225 Organon & Co shares in Q3 2022, an estimated $43.7M.
  • Smead Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Smead Capital Management's Organon & Co position peaked at $43.7M in Q2 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Smead Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.